Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Aged (1)
- Anti-Bacterial Agents (adverse effects) (1)
- Antibiotic lock (1)
- Bacteremia (1)
- Biofilm (1)
-
- Catheter-related bloodstream infection (1)
- Creatine Kinase (metabolism) (1)
- Daptomycin (1)
- Daptomycin (adverse effects) (1)
- Drug Combinations (1)
- Female (1)
- HMG-CoA (1)
- Humans (1)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects) (1)
- Male (1)
- Middle Aged (1)
- Muscular Diseases (chemically induced) (1)
- Musculoskeletal (1)
- Musculoskeletal System (drug effects) (1)
- Musculoskeletal safety (1)
- Myalgia (chemically induced) (1)
- Retrospective Studies (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Musculoskeletal Safety Outcomes Of Patients Receiving Daptomycin With Hmg-Coa Reductase Inhibitors, Christopher M. Bland, P Brandon Bookstaver, Z Kevin Lu, Brianne L. Dunn, Kathey Fulton Rumley
Musculoskeletal Safety Outcomes Of Patients Receiving Daptomycin With Hmg-Coa Reductase Inhibitors, Christopher M. Bland, P Brandon Bookstaver, Z Kevin Lu, Brianne L. Dunn, Kathey Fulton Rumley
Faculty Publications
Daptomycin, a cyclic lipopeptide antibiotic, and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) are commonly administered in the inpatient setting and are associated with creatine phosphokinase (CPK) elevations, myalgias, and muscle weakness. Safety data for coadministration of daptomycin with statins are limited. To determine the safety of coadministration of daptomycin with statin therapy, a multicenter, retrospective, observational study was performed at 13 institutions in the Southeastern United States. Forty-nine adult patients receiving statins concurrently with daptomycin were compared with 171 patients receiving daptomycin without statin therapy. Detailed information, including treatment indication and duration, infecting pathogen, baseline and subsequent CPK levels, and …
Antibiotic Lock Therapy: Review Of Technique And Logistical Challenges, Julie Ann Justo, P Brandon Bookstaver
Antibiotic Lock Therapy: Review Of Technique And Logistical Challenges, Julie Ann Justo, P Brandon Bookstaver
Faculty Publications
Antibiotic lock therapy (ALT) for the prevention and treatment of catheter-related bloodstream infections is a simple strategy in theory, yet its real-world application may be delayed or avoided due to technical questions and/or logistical challenges. This review focuses on these latter aspects of ALT, including preparation information for a variety of antibiotic lock solutions (ie, aminoglycosides, beta-lactams, fluoroquinolones, folate antagonists, glycopeptides, glycylcyclines, lipopeptides, oxazolidinones, polymyxins, and tetracyclines) and common clinical issues surrounding ALT administration. Detailed data regarding concentrations, additives, stability/compatibility, and dwell times are summarized. Logistical challenges such as lock preparation procedures, use of additives (eg, heparin, citrate, or ethylenediaminetetraacetic …